<DOC>
	<DOCNO>NCT02309307</DOCNO>
	<brief_summary>The VergenixTM STR device intend repair non rupture tendon injury ( Tendinopathy ) .</brief_summary>
	<brief_title>Tissue Repair Device ( VergenixTM STR ) Patients With Epicondylitis ( Tennis Elbow )</brief_title>
	<detailed_description>The VergenixTM STR device advance Soft tissue repair device , make lyophilized Type I rhCollagen Calcium Chloride mix autologous PRP prior injection repair non rupture tendon injury ( Tendinopathy ) . Three ( 3 ) ml mixed solution inject common extensor tendon .</detailed_description>
	<mesh_term>Tendinopathy</mesh_term>
	<mesh_term>Tennis Elbow</mesh_term>
	<mesh_term>Tendon Injuries</mesh_term>
	<criteria>1 . Man woman age 18 80 year old . 2 . Clinical diagnosis lateral epicondylitis base site pain , pain elicit active extension wrist pronation elbow extension . 3 . Documented ultrasonography diagnosis common extensor tendinosis possible tear base abnormal echotexture ( tendon thickening , anechoic area , area hypoechogencicity , loss fibrillar pattern ) . 4 . Chronic symptom ( equal great 3 month ) . 5 . PRTEE questionnaire score least 50 100 . 6 . For childbearing potential female , documentation birth control . 7 . Signing informed consent form . 1 . Acute symptom onset ( le 3 month ) . 2 . History acute elbow trauma . 3 . History Rheumatoid Arthritis . 4 . History Inflammatory disease 5 . History Fibromyalgia 6 . The patient active malignant disease kind . A patient malignant disease past , treat currently diseasefree least 5 year , may consider study entry . 7 . The patient treat anticoagulant medication 8 . The patient previously underwent surgery lateral epicondylitis . 9 . The patient previously receive local injection , include steroid within last 30 day 10 . Signs cause lateral elbow pain ( posterior interosseous nerve entrapment , osteochondral lesion ) . 11 . Wounds around elbow 12 . Likely problem , judgment investigator , maintain followup . 13 . Clinically significant abnormality hematology blood chemistry lab test screen opinion investigator might interfere patient 's safety participation study . 14 . Known positive HIV , hepatitis B , hepatitis C. 15 . Known history significant medical disorder , investigator 's judgment contraindicate patient 's participation . 16 . Known hypersensitivity and/or allergy collagen . 17 . Drug alcohol abuse ( history ) . 18 . Pregnancy childbearing potential female . 19 . Participation another study within 30 day prior screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>safety performance</keyword>
</DOC>